FATE THERAPEUTICS INC. - COMMON STOCK

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates

06 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

03 5月 2024 16:30:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

22 4月 2024 16:30:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

03 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

02 4月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

19 3月 2024 08:44:41 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

07 3月 2024 15:11:47 条件 NetDania Notify

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

05 3月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

01 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

27 2月 2024 09:45:16 条件 NetDania Notify

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

26 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

16 2月 2024 10:00:35 条件 NetDania Notify

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

15 2月 2024 10:31:27 条件 NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

15 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 12月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

08 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

27 10月 2023 14:27:31 条件 NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results

25 10月 2023 08:00:01 条件 Nasdaq GlobeNewswire